EBS: FY25 Deep Dive
FY25 revenue $743M; OI $110M; NI $53M; EPS $0.93.
Emergent BioSolutions FY25 (Dec 31, 2025) at $743M revenue. OpInc $110M; NI $53M; EPS $0.93. Pharma — Biodefense.
EBSHealthcarePharma — Biodefense·Sep 3, 2026·1 min read
EBS: FY25 Deep Dive
Emergent BioSolutions FY25 at $743M. NI $53M; EPS $0.93.
Related:EBS
Want deeper analysis?
Ask drillr anything about EBS — powered by SEC filings, earnings calls, and real-time data.
Try drillr.ai for free